Evaluation of Massachusetts State-Mandated Pilot of MOUD in Jails (032)


Study Information

In Massachusetts, individuals returning to the community are up to 120 times more likely to experience a fatal overdose than the general population.

A 2018 Massachusetts law (“Chapter 208”) established a four-year pilot program to expand the use of all FDA-approved forms of medications for opioid use disorder (MOUD) at five county jails; two additional jails voluntarily joined this pilot. The law stipulates that MOUD be maintained for individuals who were already receiving it prior to detention; initiated prior to release from jail when appropriate; and, continued in the community via facilitated linkages to local services after release.

The Massachusetts JCOIN Research Center is conducting a longitudinal treatment outcome study of individuals in these jails to examine MOUD initiation, engagement and retention, as well as fatal and non-fatal overdose and recidivism. The study will also identify strategies associated with the successful implementation of MOUD and inform the development of future strategies to address opioid use disorder in jails nationwide.

Study Settings: Jails/Prisons

Study Location: Massachusetts


Grant number:  UG1DA050067

Link to NIH Reporter record:  https://reporter.nih.gov/project-details/9882834

Study Team

PI: Liz Evans, Peter Friedmann

Logo of Baystate Health and University of Massachusetts Medical School

Study Aims

• Evaluate MOUD delivery in jail and care coordination in the community

• Measure MOUD initiation, engagement, and retention in jail and in the community

• Track utilization of health services, health status, and recidivism following release from jail

• Identify best practices to scale-up the Chapter 208 pilot program

• Estimate the economic cost of implementing MOUD programs in jail

Research Type

Clinical Trial, State Policy Rollout